Sort by:
At Teva api R&D, we work extremely closely with our customers to develop drug substances that best fit their formulation needs. In generic API development, we identify the most likely formulation and focus on potential critical attributes in the API that may impact the formulation process and properties. When providing CDMO services, our focus is […]
Teva has been awarded a 2024 EcoVadis score of 73/100, in recognition of our sustainability efforts. This score is even higher than last year, placing us in the top 4% of all pharmaceutical companies rated by EcoVadis. Receiving such a high score is not only a huge honor for Teva and Teva api, but also […]
Product Manager, Yonathan Tobis, is responsible for 50+ commercial and pipeline products in Teva api’s portfolio. See what being a product manager is all about, which skills are most valuable, and what Yonathan finds most satisfying about the role. I’m an industrial engineer by profession. I first worked as a project controller for a homeland […]
The Teva API site in Santhià, Italy, embarked on an innovative project to use artificial intelligence (AI) and machine learning (ML) to revolutionize API production. The aim was to optimize and standardize the production process to reduce variability, raw material usage, and energy consumption, while enhancing productivity and API purity. It also sought to minimize […]
API sterilization is a very niche market. But when it’s needed, it must be done right. Sterilization a crucialis a crucial step in the manufacturing of certain drug products and is key to ensuring patient safety. Over the last few years, Teva API has been developing a state-of-the-art sterilization facility in Croatia that was built […]
Last year, Teva api’s R&D leadership team got together to brainstorm about what could be done on a departmental level to make a substantial environmental impact. As a result of this meeting, a new “community” was formed called the R&D Green Community, and over the last year it has established many initiatives. The mission of […]
11 February is the International Day of Women and Girls in Science. At Teva api, women make up a large percentage of the work force and leadership positions in our R&D and manufacturing teams across the globe. Today, Andrea Szilagyi, Associate Director of R&D at our Debrecen, Hungary site, tells us what inspired her to […]
We recently held a webinar on the topic of changes and updates to global API regulation in 2023. Teva api regulatory experts from across 5 different markets – US, EU, LATAM, Japan & China, came together to talk about what’s new in each market, and to share their insights about what to be looking out […]
During COVID-19, the shortage of basic drugs in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimize shortages. Following the pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for bringing back pharma production (including finished dosages and […]
This article was originally published on 12.11.2020 and has now been updated with new information. Whether a dose form is a tablet, capsule, injection, suspension, or any another formulation, API’s physical properties play a key role in determining whether the finished dosage form will perform effectively. Particle size distribution, or PSD, is probably one of […]
Complex Generics Made Simple
